Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
03/2003
03/20/2003US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
03/20/2003US20030055091 Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators
03/20/2003US20030055068 Pyrazole compounds useful as protein kinase inhibitors
03/20/2003US20030055061 Therapy of disease or condition which is caused by a disorder of the serotonin system by administering 2,7-substituted octahydro-1H-pyrido(1,2-a)pyrazine derivatives, and their acid addition salts
03/20/2003US20030055056 For use as antitumor and immune suppressive agents, as inhibitors of proliferative cell growth and as prophylactic agents to inhibit and prevent cancer and non-malignant cell growth
03/20/2003US20030055047 For prevention and/or suppression of preterm labor, suppression of labor at term prior to caesarean delivery, and for the treatment of dysmenorrhea; useful in enhancing fertility rates
03/20/2003US20030055046 Novel pyrido cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
03/20/2003US20030055035 Useful in hyperpolarizing cell membranes, opening potassium channels, relaxing smooth muscle cells, and inhibiting bladder contractions
03/20/2003US20030055024 Administering in divided doses an effective amount of a vascular damaging agent or a pharmaceutically acceptable salt thereof for production of a vascular damaging effect in a warm-blooded animal such as a human
03/20/2003US20030054993 For contraception in a mammal, for therapy of infertility
03/20/2003US20030054549 Cell propagation mixture for use in the activation of stem cells
03/20/2003US20030054058 Vitex agnus castus extract
03/20/2003US20030054046 Hydrated dressing containing metal microbiocide
03/20/2003US20030054014 Administering fungi spores; aging resistance
03/20/2003US20030054011 Anticancer agents
03/20/2003CA2460348A1 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
03/20/2003CA2460092A1 A method of diagnosis and treatment and agents useful for same
03/20/2003CA2458029A1 Methods of treating cytokine mediated diseases
03/20/2003CA2457895A1 Prostaglandin compositions and methods of treatment for male erectile dysfunction
03/20/2003CA2457851A1 Use of hcg and lh in controlled ovarian hyperstimulation
03/20/2003CA2457849A1 Use of hcg in controlled ovarian hyperstimulation
03/20/2003CA2457067A1 Use of lh in controlled ovarian hyperstimulation
03/19/2003EP1293210A1 Means and method for hormonal contraception
03/19/2003EP1292679A1 A g-protein coupled receptor
03/19/2003EP1292674A2 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
03/19/2003EP1292620A2 Nuclear hormone receptor
03/19/2003EP1292618A2 Vip-related peptides for the treatment of sexual disorders in women
03/19/2003EP1292607A2 Novel solid body forms of mesoprogestin 11beta- 4e-(hydroxyiminomethyl)-phenyl]-17alpha-methoxymethyl-17beta-methoxy-estra-4,9-dien-3-one
03/19/2003EP1292604A1 2-aminocarbonyl-9h-purine derivatives
03/19/2003EP1292592A1 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals
03/19/2003EP1292586A1 Process for the preparation of pyrazolopyrimidinones
03/19/2003EP1292574A1 3-azabicyclo[3.1.0]hexane derivatives having opioid receptor affinity
03/19/2003EP1292572A1 Propanolaminotetralines, preparation thereof and compositions containing same
03/19/2003EP1292296A1 Pharmaceutical combination of bicalutamide and tamoxifen for providing an anti-androgenic effect and an anti-oestrogenic effect
03/19/2003EP1292295A1 Supplement to enhance fertility
03/19/2003EP1178984B1 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
03/19/2003EP1177195B1 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
03/19/2003EP1080069B1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
03/19/2003EP0595935B1 Papillomavirus Vaccine
03/19/2003CN1404485A Process of purification of hCG and recombinant hCG purified by that method
03/19/2003CN1404484A Pluraflavins and derivatives thereof, process for their preparation and use thereof
03/19/2003CN1404483A New AZa-indolyl derivatives
03/19/2003CN1404479A Novel 1,3-dihydro-2H-indol-2-one derivatives their preparing method and the pharmceutical composition containing the same
03/19/2003CN1404394A Pharmaceutical compositions containing steroidal structures and uses thereof
03/19/2003CN1403172A Medicine release controller for treating women's climacteric syndrome
03/19/2003CN1403157A Method for treating female sexual dysfunction and evaluating compound for treating female sexual dysfunction
03/19/2003CN1403155A Recombinant gamma-interferon for preventing and treating cow's recessive mammitis
03/19/2003CN1403145A Medicine composition for treating impotence and its prepn
03/19/2003CN1403117A Compound vagina-cleaning flavescent sophora lotion
03/19/2003CN1403110A Crape myrtle-hibiscus pellet
03/19/2003CN1402981A Disinfectant lotion for body's vulva and vagina
03/18/2003US6534655 Indeno[1,2-C]pyrazole derivatives for inhibiting tyrosine kinase activity
03/18/2003US6534652 Intermediates for the preparation of substituted 1,2,3,4-tetrahydronaphthalene derivatives
03/18/2003US6534518 Polysubstituted 6-phenylphenanthridines with PDE-IV inhibiting activity
03/18/2003US6534511 The use of certain 6-arylpyrazolo(3,4-d)pyrimidin-4-ones, 2 arylquinazolin-4-ones, 2-arylpurin-6-ones and 2-arylpyrido(3,2- d)pyrimidin-4-ones, or a pharmaceutically acceptable salt thereof, forsexual disorders
03/18/2003US6534490 Unsaturated 14, 15-cyclopropanoandrostanes, method for the production thereof and pharmaceutical preparations containing said compounds
03/18/2003US6534268 Isolated nucleic acid corresponding to specified nucleotide sequence that encodes human bone morphogenetic protein-7 promoter region
03/18/2003CA2236239C Quinoline and quinazoline compounds useful in therapy
03/13/2003WO2003021273A2 Diagnosis of carcinomas
03/13/2003WO2003020892A2 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY
03/13/2003WO2003020749A2 Ncam binding compounds
03/13/2003WO2003020744A1 Methylene-4-azasteroids
03/13/2003WO2003020727A1 GLYCINE-SUBSTITUTED THIENO [2,3-d]PYRIMIDINES WITH COMBINED LH AND FSH AGONISTIC ACTIVITY
03/13/2003WO2003020726A1 Thieno[2,3-d]pyrimidines with combined lh and fsh agonistic activity
03/13/2003WO2003020724A1 Polycyclic guanine phosphodiesterase v inhibitors
03/13/2003WO2003020702A2 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
03/13/2003WO2003020240A2 Therapeutic agent delivery tampon
03/13/2003WO2003020205A2 Non-mammalian gnrh analogs and uses thereof in regulation of fertility and pregnancy
03/13/2003WO2003020026A1 Methods for treating disorders using plant extracts
03/13/2003WO2003004472A8 Arylamines for the treatment of conditions associated with gsk-3
03/13/2003WO2002077217A3 Human dual specificity protein phosphatase 7-like protein
03/13/2003WO2002068388A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists
03/13/2003WO2002064091A3 Melanocortin metallopeptides for treatment of sexual dysfunction
03/13/2003WO2002060459A3 Use of iodide salt as an aphrodisiac
03/13/2003WO2002058706A3 Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy
03/13/2003WO2002050286A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
03/13/2003WO2002046191A3 Urea substituted imidazoquinoline ethers
03/13/2003WO2002046188A3 Amido ether substituted imidazoquinolines
03/13/2003WO2002045706A3 The use of polymers for inactivating pathogens
03/13/2003WO2002044379A3 Transforming growth factor-beta-related molecules and uses thereof
03/13/2003WO2002042332A3 Truncated cd200
03/13/2003US20030050461 Protein for use in the diagnosis, prevention and treatment of metabolic, developmental, nutrient transport and cell proliferation disorders
03/13/2003US20030050337 Polymorphic B Form of 3-(cyclopropylmethoxy)-4-[4(methylsulfonyl)phenyl]-5,5- dimethyl-5H-furan-2-one
03/13/2003US20030050325 Novel compounds of the indolecarboxylic family and use thereof
03/13/2003US20030050324 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
03/13/2003US20030050314 Treating bone disorder caused by osteoclasts, tumor growth and tumor metastasis, prophylaxis of cardiovascular disorders, nephropathies or retinopathies
03/13/2003US20030050309 A gelatinase inhibitor for modulating the activity of a dopamine, serotonin, or norepinephrine receptor or transporter
03/13/2003US20030050304 Therapeutic compounds
03/13/2003US20030050298 A sulfonamide substituted diphenyl thiourea compounds treating a chemokine mediated disease
03/13/2003US20030050289 Combination of drospirenone and an estrogen sulphamate for HRT
03/13/2003US20030050288 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; oral contraception using multiphase progestotational agents, antiprogestins, indole or thiophene derivatives and placebo
03/13/2003US20030050247 Peptides which are modified with at least one hydrocarbyl group and which possess antimicrobial acitivity
03/13/2003US20030050235 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator
03/13/2003US20030050234 Conotoxin peptide extracted from the venom of a marine snail, Conus magnus (cono=cone); disorders associated with voltage gated sodium ion channel; neuromuscular blocking agents; local anesthetics; neuroprotective agents; analgesics
03/13/2003US20030049823 eNOS mutations useful for gene therapy and therapeutic screening
03/13/2003US20030049706 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of bacterial infections
03/13/2003US20030049340 Use of a preparation of cimicifuga racemosa
03/13/2003US20030049279 Polysaccharide encapsualted antigen
03/13/2003CA2459937A1 Ncam binding compounds
03/13/2003CA2459161A1 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
1 ... 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 ... 557